Publication | Closed Access
Safety and Immunogenicity of a Novel Influenza Subunit Vaccine Produced in Mammalian Cell Culture
80
Citations
24
References
2009
Year
CCIV was well tolerated and highly immunogenic in adults 18 years of age or older. Cell culture may offer greater flexibility of supply during periods of high demand for both seasonal and pandemic vaccines.
| Year | Citations | |
|---|---|---|
Page 1
Page 1